Anabolic agents work differently from other osteoporosis medications in that they don't just slow down bone loss — they can trigger the growth of new bone.

Bone is not the inert structure we often imagine. It's alive, adapting daily to load-bearing and impact. But with over 200 million people affected by osteoporosis globally and therapies relying ...

Osteoporosis drug romosozumab showed no increased risk for the development of cardiovascular (CV) events compared with anabolic osteoporosis drugs, contrary to its black box warning, new research ...

According to Dr. Kendall Moseley of Johns Hopkins Medicine, treatment strategies and algorithms go out the window if the patient is not on board with he treatment plan — so it all comes back to ...

Public health institutions are facing the challenge of a lifetime as social media breeds misinformation and disinformation about everything from COVID vaccines to climate change. Now, a creative ...